SCHEMBL21246615

SCHEMBL21246615

Nc1cc(Cl)cc(C(=O)NCc2cccnc2)c1

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.60
TSHR P16473 2/20 0.57
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.57
CA2 P00918 1/20 0.56
HTT P42858 5/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 3/20 0.55
LMNA P02545 1/20 0.55
MAPT P10636 1/20 0.55
RECQL P46063 1/20 0.55
MMP13 P45452 1/20 0.54
GAA P10253 1/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
USP2 O75604 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330697 0.91 CA2 (0.62) NPC1TSHRCA2HTTALDH1A1
SCHEMBL21222741 0.85 GAA (0.61) TSHRCA2HTTSMN1; SMN2ALDH1A1
SCHEMBL29437172 0.85 NPSR1 (0.59) TSHRCA2HTTALDH1A1LMNA
SCHEMBL29437183 0.85 GAA (0.61) TSHRCA2HTTSMN1; SMN2ALDH1A1
SCHEMBL21222739 0.85 NPSR1 (0.59) TSHRCA2HTTALDH1A1LMNA
SCHEMBL11626565 0.83 NPC1 (0.81) NPC1TSHRKMT2AMEN1HTT
SCHEMBL5119797 0.83 NPC1 (0.61) NPC1TSHRCA2HTTALDH1A1
SCHEMBL29437184 0.83 NPC1 (0.61) NPC1TSHRCA2HTTALDH1A1
SCHEMBL21246547 0.82 GAA (0.70) NPC1TSHRKMT2AMEN1HTT
SCHEMBL1047604 0.81 CA2 (0.71) TSHRKMT2AMEN1CA2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2025-08-19 US disclosed
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-03-30 US disclosed
EP-3747866-B1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INST MATERIA MEDICA CAMS (CN) 2023-03-01 EP disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
CN-110092743-B Benzamide compound, preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2022-03-15 CN disclosed
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2021-02-18 US disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
WO-2019149223-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF 中国医学科学院药物研究所 2019-08-08 WO disclosed
CN-110092743-A Benzamide compound and preparation method thereof, purposes and pharmaceutical composition 中国医学科学院药物研究所 2019-08-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NPC1 3001/4885TSHR 506/4885KMT2A 413/4885
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NPC1 3001/4885TSHR 506/4885KMT2A 413/4885
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A NPC1 3001/4885TSHR 506/4885KMT2A 413/4885
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A NPC1 3001/4885TSHR 506/4885KMT2A 413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.